545 related articles for article (PubMed ID: 22182528)
1. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
2. Hydrosoluble cyclodextrin/poloxamer polypseudorotaxanes at the air/water interface, in bulk solution, and in the gel state.
Nogueiras-Nieto L; Alvarez-Lorenzo C; Sandez-Macho I; Concheiro A; Otero-Espinar FJ
J Phys Chem B; 2009 Mar; 113(9):2773-82. PubMed ID: 19708112
[TBL] [Abstract][Full Text] [Related]
3. Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine.
Nogueiras-Nieto L; Begoña Delgado-Charro M; Otero-Espinar FJ
Eur J Pharm Biopharm; 2013 Apr; 83(3):370-7. PubMed ID: 23201053
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of polypseudorotaxanes based on block-selected inclusion complexation between poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) triblock copolymers and alpha-cyclodextrin.
Li J; Ni X; Zhou Z; Leong KW
J Am Chem Soc; 2003 Feb; 125(7):1788-95. PubMed ID: 12580604
[TBL] [Abstract][Full Text] [Related]
5. Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin.
Simões SM; Veiga F; Torres-Labandeira JJ; Ribeiro AC; Sandez-Macho MI; Concheiro A; Alvarez-Lorenzo C
Eur J Pharm Biopharm; 2012 Jan; 80(1):103-12. PubMed ID: 22005155
[TBL] [Abstract][Full Text] [Related]
6. Selective interaction of 2,6-di-O-methyl-β-cyclodextrin and Pluronic F127 micelles leading to micellar rupture: a nuclear magnetic resonance study.
Castiglione F; Valero M; Dreiss CA; Mele A
J Phys Chem B; 2011 Jul; 115(29):9005-13. PubMed ID: 21667967
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
[TBL] [Abstract][Full Text] [Related]
8. Preparation of alpha-cyclodextrin-terminated polyrotaxane consisting of beta-cyclodextrins and pluronic as a building block of a biodegradable network.
Ooya T; Ito A; Yui N
Macromol Biosci; 2005 May; 5(5):379-83. PubMed ID: 15895475
[TBL] [Abstract][Full Text] [Related]
9. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
10. Triamcinolone solubilization by (2-hydroxypropyl)-β-cyclodextrin: A spectroscopic and computational approach.
Miro A; Ungaro F; Balzano F; Masi S; Musto P; La Manna P; Uccello-Barretta G; Quaglia F
Carbohydr Polym; 2012 Oct; 90(3):1288-98. PubMed ID: 22939343
[TBL] [Abstract][Full Text] [Related]
11. An ocular drug delivery system containing zinc diethyldithiocarbamate and HPbetaCD inclusion complex--corneal permeability, anti-cataract effects and mechanism studies.
Wang S; Li D; Ito Y; Liu X; Zhang J; Wu C
J Pharm Pharmacol; 2004 Oct; 56(10):1251-7. PubMed ID: 15482639
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
13. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
14. Evidence of formation of site-selective inclusion complexation between beta-cyclodextrin and poly(ethylene oxide)-block-poly(propylene oxide)- block-poly(ethylene oxide) copolymers.
Tsai CC; Zhang WB; Wang CL; Van Horn RM; Graham MJ; Huang J; Chen Y; Guo M; Cheng SZ
J Chem Phys; 2010 May; 132(20):204903. PubMed ID: 20515110
[TBL] [Abstract][Full Text] [Related]
15. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Wang S; Ding Y; Yao Y
Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
[TBL] [Abstract][Full Text] [Related]
16. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
[TBL] [Abstract][Full Text] [Related]
17. Budesonide-hydroxypropyl-β-cyclodextrin inclusion complex in binary poloxamer 407/403 system for ulcerative colitis treatment: A physico-chemical study from micelles to hydrogels.
Santos Akkari AC; Ramos Campos EV; Keppler AF; Fraceto LF; de Paula E; Tófoli GR; de Araujo DR
Colloids Surf B Biointerfaces; 2016 Feb; 138():138-47. PubMed ID: 26674842
[TBL] [Abstract][Full Text] [Related]
18. Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability.
Siemoneit U; Schmitt C; Alvarez-Lorenzo C; Luzardo A; Otero-Espinar F; Concheiro A; Blanco-Méndez J
Int J Pharm; 2006 Apr; 312(1-2):66-74. PubMed ID: 16464549
[TBL] [Abstract][Full Text] [Related]
19. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
Nie S; Zhang S; Pan W; Liu Y
Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
